Trials / Sponsors / Venus MedTech (HangZhou) Inc.
Venus MedTech (HangZhou) Inc.
Industry · 7 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | VenusP-Valve™ System Long-term Follow-up 6-10 Years Native Right Ventricle Outflow Tract(RVOT) Dysfunction | — | 2026-05-01 |
| Recruiting | Observational Study of Venus P-Valve Right Ventricular Outflow Tract Dysfunction | — | 2024-08-26 |
| Recruiting | VenusP-Valve Pivotal Study (PROTEUS STUDY) Pulmonary Regurgitation | N/A | 2024-06-11 |
| Not Yet Recruiting | Venus-Vitae Pivotal Study Smart-Align Study Aortic Valve Stenosis | N/A | 2023-10-31 |
| Unknown | Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts Pulmonary Regurgitation | N/A | 2016-08-17 |
| Unknown | Efficacy and Safety of Venus P-valve to Treat RVOT Stenosis With Pulmonary Regurgitation Right Ventricular Outflow Tract Stenosis | Phase 3 | 2014-02-01 |
| Unknown | Safety and Performance of TAVI of Venus MedTech Aortic Valve Prosthesis Aortic Valve Stenosis, Aortic Valve Calcification | N/A | 2012-09-01 |